Bill Amendment: FL S0966 | 2013 | Regular Session
NOTE: For additional amemendments please see the Bill Drafting List
Bill Title: Health Care
Status: 2013-05-03 - Died on Calendar, companion bill(s) passed, see CS/HB 1071 (Ch. 2013-93), CS/CS/HB 1159 (Ch. 2013-153), SB 1520 (Ch. 2013-48) [S0966 Detail]
Download: Florida-2013-S0966-Senate_Floor_Amendment_314864.html
Bill Title: Health Care
Status: 2013-05-03 - Died on Calendar, companion bill(s) passed, see CS/HB 1071 (Ch. 2013-93), CS/CS/HB 1159 (Ch. 2013-153), SB 1520 (Ch. 2013-48) [S0966 Detail]
Download: Florida-2013-S0966-Senate_Floor_Amendment_314864.html
Florida Senate - 2013 SENATOR AMENDMENT Bill No. CS for CS for SB 966 Barcode 314864 LEGISLATIVE ACTION Senate . House . . . . . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— Senator Grimsley moved the following: 1 Senate Amendment (with title amendment) 2 3 Between lines 3831 and 3832 4 insert: 5 Section 86. Paragraph (b) of subsection (2), subsection 6 (10), and paragraph (c) of subsection (11) of section 893.055, 7 Florida Statutes, is amended to read: 8 893.055 Prescription drug monitoring program.— 9 (2) 10 (b) The department, when the direct support organization11receives at least $20,000 in nonstate moneys or the state12receives at least $20,000 in federal grants for the prescription13drug monitoring program,shall adopt rules as necessary 14 concerning the reporting, accessing the database, evaluation, 15 management, development, implementation, operation, security, 16 and storage of information within the system, including rules 17 for when patient advisory reports are provided to pharmacies and 18 prescribers. The patient advisory report shall be provided in 19 accordance with s. 893.13(7)(a)8. The department shall work with 20 the professional health care licensure boards, such as the Board 21 of Medicine, the Board of Osteopathic Medicine, and the Board of 22 Pharmacy; other appropriate organizations, such as the Florida 23 Pharmacy Association, the Florida Medical Association, the 24 Florida Retail Federation, and the Florida Osteopathic Medical 25 Association, including those relating to pain management; and 26 the Attorney General, the Department of Law Enforcement, and the 27 Agency for Health Care Administration to develop rules 28 appropriate for the prescription drug monitoring program. 29 (10) All costs incurred by the department in administering 30 the prescription drug monitoring program shall be funded through 31 state funds, federal grants, or private funding applied for or 32 received by the state. The department may not commit funds for 33 the monitoring program without ensuring funding is available. 34The prescription drug monitoring program and the implementation35thereof are contingent upon receipt of the nonstate funding.The 36 department and state government shall cooperate with the direct 37 support organization established pursuant to subsection (11) in 38 seeking state funds, federal grant funds, other nonstate grant 39 funds, gifts, donations, or other private moneys for the 40 department ifso long asthe costs of doing so are not 41 considered material. Nonmaterial costs for this purpose include, 42 but are not limited to, the costs of mailing and personnel 43 assigned to research or apply for a grant. Notwithstanding the 44 exemptions to competitive-solicitation requirements under s. 45 287.057(3)(f), the department shall comply with the competitive 46 solicitation requirements under s. 287.057 for the procurement 47 of any goods or services required by this section.Funds48provided, directly or indirectly, by prescription drug49manufacturers may not be used to implement the program.50 (11) The department may establish a direct-support 51 organization that has a board consisting of at least five 52 members to provide assistance, funding, and promotional support 53 for the activities authorized for the prescription drug 54 monitoring program. 55 (c) The State Surgeon General shall appoint a board of 56 directors for the direct-support organization. Members of the 57 board shall serve at the pleasure of the State Surgeon General. 58 The State Surgeon General shall provide guidance to members of 59 the board to ensure that moneys received by the direct-support 60 organization are not received from inappropriate sources. 61 Inappropriate sources include, but are not limited to, donors, 62 grantors, persons,ororganizations, or pharmaceutical 63 companies, that may monetarily or substantively benefit from the 64 purchase of goods or services by the department in furtherance 65 of the prescription drug monitoring program. 66 67 ================= T I T L E A M E N D M E N T ================ 68 And the title is amended as follows: 69 Delete line 354 70 and insert: 71 conform to changes made by the act; amending s. 72 893.055, F.S.; deleting obsolete provisions; deleting 73 a provision that prohibits funds from prescription 74 drug manufacturers to be used to implement the 75 prescription drug monitoring program; authorizing the 76 prescription drug monitoring program to be funded by 77 state funds; revising the sources of money which are 78 inappropriate for the direct-support organization of 79 the prescription drug monitoring program to receive; 80 creating s.